Volume 51, Issue 6, Pages (June 2007)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Volume 60, Issue 2, Pages (August 2011)

Volume 68, Issue 6, Pages (December 2015)

Volume 52, Issue 1, Pages (July 2007)

Volume 172, Issue 6, Pages (December 2004)

Volume 68, Issue 3, Pages (September 2015)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 58, Issue 1, Pages (July 2010)

Volume 55, Issue 2, Pages (February 2009)

Volume 65, Issue 3, Pages (March 2014)

Volume 62, Issue 4, Pages (October 2012)

Volume 56, Issue 5, Pages (November 2009)

Volume 58, Issue 1, Pages (July 2010)

Volume 60, Issue 2, Pages (August 2011)

Renal Cell Carcinoma: Prognostic Factors and Patient Selection

Volume 67, Issue 5, Pages (May 2015)

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 1, Pages (January 2007)

Volume 53, Issue 4, Pages (April 2008)

Volume 52, Issue 3, Pages (September 2007)

Volume 51, Issue 4, Pages (April 2007)

Volume 51, Issue 3, Pages (March 2007)

Volume 69, Issue 1, Pages 4-6 (January 2016)

Lymph Node Dissection in Renal Cell Carcinoma

Volume 54, Issue 4, Pages (October 2008)

Volume 68, Issue 1, Pages (July 2015)

Volume 56, Issue 3, Pages (September 2009)

Volume 60, Issue 4, Pages (October 2011)

Volume 63, Issue 1, Pages (January 2013)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 61, Issue 5, Pages (May 2012)

Volume 52, Issue 5, Pages (November 2007)

Volume 65, Issue 3, Pages (March 2014)

Volume 55, Issue 2, Pages (February 2009)

Volume 52, Issue 1, Pages (July 2007)

Volume 57, Issue 4, Pages (April 2010)

Introduction to small renal tumours and prognostic indicators

Volume 60, Issue 5, Pages (November 2011)

Reassessing the Current UICC/AJCC TNM Staging for Renal Cell Carcinoma

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 61, Issue 6, Pages (June 2012)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 52, Issue 2, Pages (August 2007)

Volume 61, Issue 2, Pages (February 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 62, Issue 2, Pages (August 2012)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

Volume 56, Issue 5, Pages (November 2009)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations? Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri

Volume 50, Issue 3, Pages (September 2006)

Volume 52, Issue 6, Pages (December 2007)

Volume 71, Issue 5, Pages (May 2017)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 54, Issue 4, Pages (October 2008)

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Volume 54, Issue 1, Pages (July 2008)

European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why? Jean-Jacques Patard

European Urology Oncology

Volume 53, Issue 6, Pages (June 2008)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Volume 54, Issue 1, Pages (July 2008)

Presentation transcript:

Volume 51, Issue 6, Pages 1616-1624 (June 2007) Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival Pierre I. Karakiewicz, Quoc-Dien Trinh, Naeem Bhojani, Karim Bensalah, Laurent Salomon, Alexandre de la Taille, Jacques Tostain, Luca Cindolo, Vincenzo Altieri, Vincenzo Ficarra, Luigi Schips, Richard Zigeuner, Peter F.A. Mulders, Antoine Valeri, Jean-Luc Descotes, Arnaud Mejean, Jean-Jacques Patard European Urology Volume 51, Issue 6, Pages 1616-1624 (June 2007) DOI: 10.1016/j.eururo.2006.12.015 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 Specific survival for 167 TanyN1–2M0 patients treated for renal cell carcinoma. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 2 Renal cell carcinoma-specific survival in 3907 patients stratified according to disease stage: TanyN0M0, TanyN+M0, TanyNanyM+. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 3 Renal cell carcinoma-specific survival in subset of 157 patients stratified according to T stage. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 4 Renal cell carcinoma-specific survival in subset of 157 patients stratified according to tumour size quartiles. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 5 Renal cell carcinoma-specific survival in subset of 157 patients stratified according to Fuhrman grade. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 6 Renal cell carcinoma-specific survival in subset of 157 patients stratified according to histologic type. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 7 Renal cell carcinoma-specific survival in subset of 157 patients stratified according to symptom classification. European Urology 2007 51, 1616-1624DOI: (10.1016/j.eururo.2006.12.015) Copyright © 2006 European Association of Urology Terms and Conditions